de Soto-Álvarez, T. (Teresa)

Filtering

20201

Settings

Author search.filters.isAuthorOfPublication.06d9b1ae-c16e-4c0e-b827-09a77803197e

Search Results

Now showing 1 - 1 of 1
  • Thumbnail Image
    Managing the front-line treatment for diffuse large B cell lymphoma and high-grade B cell lymphoma during the COVID-19 outbreak
    (2020) López, A. (Andrés); de la Cruz-Benito, B. (Beatriz); Lopez-de-la-Guía, A. (Ana); de Soto-Álvarez, T. (Teresa); Sánchez-Vadillo, I. (Irene); Dos-Santos-Ortas, A. (Abel); Casado-Abad, G. (Gema); Canales-Albendea, M. A. (Miguel Ángel); Lázaro-Del-Campo, P. (Paula); Humala-Barbier, K. (Karem); Jiménez-Yuste, V. (Víctor)
    The COVID-19 pandemic has dramatically challenged care for cancer patients, especially those with active treatment who represent a vulnerable population for SARS-CoV-2 infection. Aggressive lymphoid neoplasms, such as diffuse large B cell lymphoma and high-grade B cell lymphoma, need to be treated without delay in order to get the best disease outcome. Because of that, our clinical practice was changed to minimise the risk of SARS-CoV-2 infection while continuing haematological treatment. In this report, we analyse the management of front-line therapy in 18 patients during the COVID-19 outbreak, as well as the results of the implemented measures in their outcome.